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Background: Different levels of brain arousal can be delineated not only during
sleep but also during wakefulness. Electroencephalography (EEG) is the gold standard to
assess different levels of brain arousal. A novel EEG- and electrooculography (EOG)-based
tool, the Vigilance Algorithm Leipzig (VIGALL 2.0), allows determining the level of
EEG-vigilance (indicating brain arousal). Considering the frequency patterns and
LORETA-based cortical distribution of electroencephalic activity, VIGALL 2.0 automatically
attributes one out of seven vigilance stages to each EEG segment (1-sec EEG segments
by default), ranging from high alertness (stage 0), to relaxed wakefulness (stage A1 to A3),
to drowsiness (stage B1 to B2/3) up to sleep onset (stage C). Building on the time series
of these seven vigilance stages across 20 min, two parameterizations of the
temporal dynamic (brain arousal regulation) are calculated: the lability score and
the slope index.
Methods: 27 healthy participants (age = 22.93 ± 3.44 years, 18 females) underwent two
sessions (7 days apart) of a twenty-minute eyes-closed resting EEG paradigm.
Results: The test-retest reliability coefficients for the EEG-vigilance stages were between
rho = .53 and .86 (all p < .01). For the temporal dynamic of the stages across
20 min, the test-retest reliability coefficients were rho = .70 (lability score, p < .001)
and .71 (slope index, p < .001).
Conclusions: This study demonstrated some trait aspects of brain arousal regulation by
confirming the stability of temporal dynamic of EEG-vigilance stages as assessed
with VIGALL 2.0. Considering the “first day in lab” effect identified in the present
study, more adaptation to the lab surrounding and a stricter control of other state
factors should be taken into account, which might improve reliability. Additionally, in a
clinical context, a broader range of brain arousal regulation patterns might be
found, possibly leading to higher test-retest reliability than was found in this
homogenous healthy sample. This would be desirable, as parameters of brain
arousal regulation are promising diagnostic and prognostic biomarkers for diseases with
arousal disturbances, such as affective disorders, ADHD and fatigue.
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Brain arousal influences all human behaviours (Pfaff et al. 2008). Arousal regulation de-
notes the adaptation of brain arousal to situational requirements, which is of most im-
portance for efficient human behavior. For example, arousal must be heightened in
case of potential danger, maintained during cognitive tasks and reduced at bedtime.
Recently, the Research Domain Criteria (RDoC) project of the National Institute of
Mental Health has implemented arousal as a fundamental dimension of psychopath-
ology (Cuthbert and Insel 2013).
Different levels of brain arousal can be delineated not only during sleep (e.g. Iber
et al. 2008; Rechtschaffen and Kales 1969) but also during wakefulness (see below).
Electroencephalography (EEG) is the gold standard to assess different levels of brain
arousal. By taking into account the frequency patterns as well as the Low Resolution
Electromagnetic Tomography (LORETA)-based cortical distribution of EEG activity,
different EEG-vigilance stages (indicating brain arousal states) can be distinguished
during the transition from high alertness to relaxed wakefulness, to drowsiness up
to sleep onset.
Under eyes-closed resting conditions without external stimulation, interindividual differ-
ences concerning arousal regulation occur (Hegerl and Hensch 2014): Most subjects show
progressive declines to lower EEG-vigilance stages indicating slowly-declining arousal regu-
lation, while some subjects display an unstable arousal regulation with rapid declines to low
EEG-vigilance stages after only a few seconds. Yet others exhibit a hyperstable arousal regu-
lation without such declines to lower EEG-vigilance stages even after recording periods of
20 min - the EEG recording period following the standard operating procedures of VIGALL
(available at http://research.uni-leipzig.de/vigall/) and the Multiple Sleep Latency Test
(MSLT; Carskadon and Dement 1977). Brain arousal regulation can be considered a state
modulated trait, because sleep deficits or drugs with arousal stabilizing properties (e.g. caf-
feine, nicotine) are likely to exert state dependent influences.
EEG parameters of brain arousal regulation (i.e. the temporal dynamic of EEG-vigilance
stages) can be considered converging biomarkers reflecting influences of various wakeful-
ness and sleep promoting neurochemical systems (e.g. the noradrenergic, histaminergic, se-
rotonergic and orexinergic system). These biomarkers are not only of interest as
neurobiological correlates of arousal regulation but also as indicators of pathogenetic as-
pects in affective disorders and attention-deficit/hyperactivity disorder (ADHD) (Geissler
et al. 2014; Hegerl and Hensch 2014).
According to the classification by Rechtschaffen and Kales (1969) and the scoring
manual of the American Academy of Sleep Medicine (Iber et al. 2008), brain arousal
has traditionally been classified into 3 stages: relaxed wakefulness, non-rapid eye
movement sleep (NREM) and rapid eye movement sleep (REM). However, these
traditional classifications do not distinguish sub-stages preceding sleep onset,
although such sub-stages during transition from wakefulness to sleep onset have
been described for decades (Bente 1964; Loomis et al. 1937; Roth 1961; Benca et al.
1999; Cantero et al. 2002; Corsi-Cabrera et al. 2000; De Gennaro et al. 2001, 2004,
2005; De Gennaro and Ferrara 2003; Kaida et al. 2006; Marzano et al. 2007;
Strijkstra et al. 2003; Tsuno et al. 2002). Building on this research, a novel EEG-
based algorithm for automatic classification of EEG-vigilance stages has recently
been introduced by Hegerl and colleagues (Sander et al. in press).
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(EOG)-based algorithm which allows to objectively determine the level of EEG-vigilance
and its dynamics within EEG recordings (Hegerl et al. 2014; Hegerl and Hensch 2014;
Olbrich et al. 2012; Sander et al. in press). The algorithm considers the frequency patterns
as well as the cortical distribution of EEG activity, using EEG source localisation approaches
(LORETA; Pascual-Marqui et al. 1994; Pascual-Marqui et al. 2002). VIGALL 2.0 automatic-
ally attributes one out of seven EEG-vigilance stages (Table 1) to each EEG segment (1-sec
EEG segments by default). Building on the time series of these seven EEG-vigilance stages
across 20 min, two parameterizations of the temporal dynamic are calculated: the lability
score and the slope index (as described below).
Because of the high inter-individual variability in electroencephalic frequency patterns
and power, VIGALL 2.0 has adaptive features concerning individual alpha peaks and amp-
litude levels. VIGALL 2.0 should not be used for EEGs showing alpha variant rhythms or
major modifications due to drugs (e.g. anticholinergic drugs) or certain diseases (e.g. se-
vere Alzheimer’s disease). Additionally, VIGALL 2.0 is not indicated for EEGs from chil-
dren younger than ten years (or older children in case of delayed maturation). VIGALL
2.0 is implemented as an add-in in the Brain Vision Analyzer 2.0 software (Brain Products,
Gilching, Germany). The VIGALL 2.0 add-in as well as the user manual including the
standard operating procedures (SOPs) can freely be downloaded from http://
research.uni-leipzig.de/vigall/.
VIGALL 2.0 is a refinement of an earlier version of the algorithm, which has been
validated using simultaneous EEG-fMRI (Olbrich et al. 2009) as well as simultan-
eous EEG-FDG-PET-studies (Günther et al. 2011) and by relating the EEG-vigilance
stages to different autonomic parameters (Olbrich et al. 2011b). Moreover, VIGALL
has already been applied in clinical studies. In line with the arousal regulation theory of
affective disorders and ADHD (Hegerl and Hensch 2014; Geissler et al. 2014), a hyperstable
arousal regulation has been shown in depressive patients compared with controls (Hegerl
et al. 2012; Olbrich et al. 2012), and, in contrast, an unstable arousal regulation has been
shown in ADHD (Olbrich et al. 2013; Sander et al. 2010).
Having in mind the potential use of EEG parameters of brain arousal regulation as
diagnostic or predictive biomarkers, the aim of this study was to assess the test-
retest reliability of lability score, slope index, EEG-vigilance stages and mean EEG-
vigilance level as assessed by VIGALL in healthy subjects.Table 1 Arousal states and EEG descriptions of EEG-vigilance stages
VIGALL arousal state EEG
0 high alertness low amplitude EEG with high beta (12–25 Hz) power without
horizontal slow eye movements
A1 relaxed wakefulness dominant high alpha (8–12 Hz) in occipital regions of interest
A2 dominant high alpha (8–12 Hz) in parietal or temporal regions
of interest
A3 dominant high alpha (8–12 Hz) in frontal regions of interest
B1 low amplitude EEG with high beta (12–25 Hz) power with
horizontal slow eye movements
B2/3 drowsiness high delta (2–4 Hz) or theta (4–8 Hz) power
C sleep onset K-complexes or sleep spindles
Vigilance Algorithm Leipzig (VIGALL)
Huang et al. Neuropsychiatric Electrophysiology  (2015) 1:13 Page 4 of 13Methods
Participants
Participants were recruited via local and online advertisements. They gave written in-
formed consent and received an expense allowance. The study was approved by the
local ethics committee of the University of Leipzig (075-13-11032013). Participants
were requested to participate in two EEG measures with the average interval of 7.15
(±1.29; range: 4–11) days between both. 27 participants (18 females; age = 22.93 ±
3.44 years) had two EEG recordings (T1 and T2) available and met the following inclu-
sion criteria: no pathological sleepiness (defined as score above 14 of Epworth Sleepi-
ness Scale; see Johns 1992), which may artificially increase retest reliability, no
extensive sleep duration difference between both nights prior to each session (i.e. more
than 2 hours as assessed by sleep protocol) and no reported history of psychiatric or
neurological disorders or current consumption of psychotropic medication. Participants
were allowed to drink caffeinated beverages and to smoke as usual prior to the EEG re-
cording at T1 and T2.EEG recording
During EEG preparation participants were asked to fill in questionnaires including a sleep
protocol, which contained questions about last night’s sleep, a substance consumption scale,
the Epworth Sleepiness Scale (ESS, German version available at http://www.charite.de/
dgsm/dgsm/fachinformationen_frageboegen_epworth.php) and the Karolinska Sleepiness
Scale (KSS; Akerstedt and Gillberg 1990). EEG was recorded within a timeslot between 1
and 4 p.m. depending on time arrangement with the participants. Daytime of EEG
assessment was kept constant for each participant across both sessions. The recording
booth was a light dimmed and sound attenuated room with a maintained temperature be-
neath 25 ° C. The participants lay comfortably on a lounger with closed eyes and were
instructed to relax and not to try staying awake in case of drowsiness. Rather, they
were explicitly allowed to follow their natural course of arousal. EEG assessment
started with a Berger Maneuver (i.e. alternating opening and closing of the eyes).
The resting EEG recording in each session lasted for 20 min.
The EEG was recorded by 40 channel QuickAmp amplifiers (Brain Products GmbH,
Gilching, Germany) from 32 electrode sites and no online filter was applied. Electrodes
were arranged according to the extended international 10–20 system using EasyCap
(EASYCAP Brain Products GmbH, Gilching, Germany), and referenced against com-
mon average. Impedances were kept below 10 kΩ and sampling rate was 1000 Hz.
Electrodes for horizontal EOG (hEOG) were placed lateral of the left and right eye,
electrodes for vertical EOG (vEOG) were placed above and beneath the right eye.EEG preprocessing and vigilance classification
EEG data were processed using Brain Vision Analyzer 2.0 software (Brain Products GmbH,
Gilching, Germany). EEG raw data was filtered offline (highpass at .5 Hz, lowpass at 70 Hz,
notch-filter at 50 Hz (±5 Hz). EOG raw data was filtered the same way as EEG raw data but
without a highpass filter. The 20 min resting EEG was subdivided into 1200 consecutive
1-sec segments. Following a visual artifact screening, an independent component analysis
(ICA) was performed. Eye movement and continuous muscle artifacts were removed by
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et al. 2011a). Afterwards, the EEG segments were visually screened again for remaining
muscle, swallow, eye movement and sweating artifacts. To keep the time sequence intact,
artifact-containing segments were not removed but marked manually and discarded from
further classification. EEG recordings with more than 90 % of artifacts free segments were
included in the analysis. This criterion was achieved by all subjects: There were 1173.30
(±25.53, range: 1087–1199) and 1172.22 (±19.00, range: 1127–1196) artifact free EEG seg-
ments at T1 and T2, respectively.
Subsequently, all segments were classified into seven different vigilance stages using VIG-
ALL 2.0 (for detailed descriptions of the scoring algorithm see the VIGALL 2.0 Manual
(available at http://research.uni-leipzig.de/vigall/). Classification of vigilance stage C relies
on the occurrence of graph elements indicating sleep onset (i.e. K-complex or sleep
spindles). Therefore, all EEGs had visually been screened for such graph elements
and the respective EEG segments had been marked.EEG-vigilance parameterizations
For each recording, results of the VIGALL classification via VIGALL 2.0 are written
into an output text file which was then imported into a customized Excel template with
Visual Basic for Applications (VBA) macros (Microsoft), and used to calculate different
parameterizations of brain arousal and its dynamics.a) Amount of EEG-vigilance stages: Over the whole recording period, the relative
amount of segments attributed to the respective EEG-vigilance stages (stage 0, A, B
and C, sub-stages A1, A2, A3, B1, B2/3) was determined (amount*100/total number
of non-artifact segments).
b) Mean EEG-vigilance level: As a parameterization of the overall EEG-vigilance level, each
EEG-vigilance stage was assigned with a number ranging from 7 (highest vigilance
stage 0) to 1 (lowest vigilance stage C). Based on that, a mean EEG-vigilance level
was calculated by averaging the vigilance scores of all non-artifact segments. In
order to assess the temporal dynamics of the EEG-vigilance level, the 20 min resting
EEG was subdivided into four consecutive blocks (block 1: minute 1–5; block 2: minute
6–10; block 3: minute 11–15; block 4: minute 16–20) and the mean EEG-vigilance level
was computed for each block.
c) Lability score: To quantify the speed and extend of vigilance decline, a so called
“lability score” was determined for each individual vigilance time course (see
Table 2). To this end, epochs of 1 min duration (i.e. 60 1-sec segments) were
analyzed (epoch 1: segments 1–60, epoch 2: segments 2-61…). For each epoch,
it was tested if one of the following conditions applied (in ascending order
according to lability): (I) occurrence of at least 1 C-stage; (II) at least 1/3 of
segments classified as B2/3-stage; (III) at least 1/3 of all segments classified as
B-stages (B1 + B2/3); (IV) at least 2/3 of all segments classified as 0/A- or 0/
A1-stages. If within the whole EEG data only criterion IV was fulfilled, a
lability score of 1 or 2 was given. If one of the other criteria was fulfilled in
at least one epoch, we determined the EEG part in which the lowest vigilance stage was
reached for the first time and gave the respective “lability score” (as seen in Table 2).
Table 2 Lability score correspond to certain EEG-vigilance stage in the respective EEG block
(20 min EEG recording separated in 4 blocks of 5 min duration)
Lability Score Lability level (criterion) EEG block Operational definition
1 level 1: less than 1/3 of all segments not
classified as 0/A- or 0/A1-stages
1-4 rigidity, unique appearance of 0 and A1
2 1-4 rigidity, unique appearance of 0 and A
3 level 2: at least 1/3 of all segments
classified as B (B1 + B2/3)-stages
4 stage B emerged in minute 16-20
4 3 stage B emerged in minute 11-15
5 2 stage B emerged in minute 6-10
6 1 stage B emerged in minute 1-5
7 Level 3: at least 1/3 of segments
classified as B2/3-stages
4 stage B2/3 emerged in minute 16-20
8 3 stage B2/3 emerged in minute 11-15
9 2 stage B2/3 emerged in minute 6-10
10 1 stage B2/3 emerged in minute 1-5
11 Level 4: occurrence of at least 1 C-stage 4 stage C emerged in minute 16-20
12 3 stage C emerged in minute 11-15
13 2 stage C emerged in minute 6-10
14 1 stage C emerged in minute 1-5
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functional equations n f xð Þ ¼ m ﬃﬃﬃﬃﬃﬃﬃlnxp þ n , which take into account the initial
mean EEG-vigilance level observed in minute one (n, with 1 ≤ n ≤ 7) and its
square rooted logarithmic decline to the mean level in each of the subsequent




with x representing the count of the respective
minute; 2 ≤ x ≤ 20). Arousal instability was defined as the slope (m) with the
lowest value (reflecting the steepest decline) as derived from the nineteen
possible functional equations. The square rooted logarithmic relation enables an
objective and adequate weighting of immediate drops to moderate EEG-vigilance
levels relative to delayed drops to low EEG-vigilance levels. Within an independent
sample comprising 1079 healthy participants of the Leipzig Health Care Study (556
males, age = 65.6 years), regression analyses revealed a linear negative relation between
mean EEG-vigilance level during minute one and m (b = −.33, t =−10.875, p < .001). To
compensate floor effects within participants exhibiting low initial EEG-vigilance levels,
individual slopes were adjusted by adding a linear correction factor (−0.33 ∗(7−n)).Statistics
Paired two samples Wilcoxon signed ranks tests were carried out to determine whether
scores of T1 and T2 differed significantly from each other. For all correlational analyses
nonparametric Spearman rank correlation rho was calculated, since the data were
either ordinal scaled (lability score and slope index) or not normally distributed
(amount of vigilance stages with exception of stage A1 and B2/3).Results
Test-retest reliability of EEG-vigilance stages
EEG-vigilance stages (in % of all artifact free 1-sec EEG segments) at T1 and T2 are
presented in Table 3. Except higher amounts of stage 0 (Z = −2.30, p = .022) and lower
Table 3 EEG-vigilance stages (in % of all artifact free 1-sec segments across 20 min of EEG recording).
Mean differences between T1 and T2 and respective Spearman correlation confidents (N = 27)
EEG-vigilance
stages
T1 T2 Z (p) rho (p)
proportion (SD) range proportion (SD) range
stage 0 5.61 (8.81) .00-33.73 3.04 (5.63) .00-23.99 −2.30 (.022) .529 (.005)
stage A 49.23 (25.83) 1.51-94.43 44.23 (31.54) 2.17-97.46 −1.97 (.049) .855 (.000)
sub-stage A1 32.08 (17.02) .50-66.97 30.07 (23.80) .42-96.10 −1.07 (.285) .680 (.000)
sub-stage A2 12.56 (14.70) .17-48.12 10.48 (14.70) .17-66.16 −1.38 (.167) .700 (.000)
sub-stage A3 4.59 (8.54) .00-39.10 3.68 (8.08) .00-38.43 −1.09 (.276) .776 (.000)
stage B 36.52 (18.69) 3.51-76.45 40.76 (23.42) 2.20-83.69 −1.39 (.163) .569 (.002)
sub-stage B1 18.62 (15.28) .67-50.88 17.15 (16.37) .34-54.49 −1.09 (.313) .590 (.001)
sub-stage B23 17.89 (14.12) .09-48.28 23.61 (17.30) .00-57.18 −2.15 (.032) .657 (.000)
stage C 8.65 (12.18) .00-41.05 11.97 (17.23) .00-56.06 −1.24 (.215) .859 (.000)
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did not show any statistically significant differences between T1 and T2. Notice that
the significant difference was also obtained for entire A (Z = −1.97, p = .049) but not for
the comparisons between sub-stage A1, A2 and A3 (all p > .05). The test-retest correl-
ation coefficients were all significant (all p < .01; see Table 3).Test-retest reliability of mean EEG-vigilance level
Mean EEG-vigilance level for 20 min (overall) and the 5–minutes blocks are shown
in Table 4. The overall EEG-vigilance level was significantly lower in T2 (Z = −2.35,
p = .019). A significant difference was also found for mean EEG-vigilance level of
the first block (minute 1–5) (Z = −2.22, p = .026). The effect size between T1 and
T2, as presented in Table 4, for overall and mean EEG-vigilance level in correspond-
ing time blocks varied between .19 and .49, which indicated a small to medium
effect based on Cohen’s criterion (Cohen 1988). The correlation coefficients are
also illustrated in Table 4. With exception of the first block (minute 1–5), all mean vigi-
lance levels demonstrated temporal stability with correlation coefficients of rho ≥ .659
(all p < .001; see Table 4).Test-retest reliability of temporal dynamic: lability score
The cumulative frequency distribution and scatter plot of the lability scores in T1
and T2 are illustrated respective in Figs. 1 and 2. The test-retest correlation of labil-
ity score was rho = .704 (p < .001).Table 4 Mean EEG-vigilance level for 20 min (overall) and the 5–minutes blocks. Differences
between T1 and T2 and respective Spearman correlation coefficients (N = 27)
Time block T1 (SD) T2 (SD) effect size d Z (p) rho (p)
overall 4.13 (0.95) 3.80 (1.17) .31 −2.35 (.019) 0.700 (.000)
1 5.26 (0.66) 4.83 (1.05) .49 −2.22 (.026) 0.377 (.052)
2 4.35 (1.09) 4.01 (1.37) .27 −1.71 (.088) 0.758 (.000)
3 3.68 (1.31) 3.39 (1.43) .21 −1.44 (.149) 0.692 (.000)
4 3.23 (1.49) 2.95 (1.46) .19 −1.23 (.220) 0.659 (.000)
Fig. 1 Cumulative frequency distribution of lability score in T1 and T2 (N = 27). Dots illustrated the cumulative
frequency in the corresponding lability score. The line with black dots represented the cumulative
frequency distribution in T1, while the line with grey dots represented the cumulative distribution in T2
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The slope indices for T1 and T2 are represented as scatter plot in Fig. 3. The test-
retest correlation of logarithmic slope index to the corrected sample size was
rho = .714 (p < .001).Discussion
The current study analyzed for the first time test-retest reliability of EEG parameters of brain
arousal regulation in a sample of young individuals. The nonparametric test-retest correl-
ation coefficients for single EEG-vigilance stages varied from .53 to .86 (all p < .01), those for
mean EEG-vigilance levels with exception of block 1 between .66 and .76 (all p < .001), andFig. 2 Scatter plot of lability score at T1 vs. T2 (N = 27). The horizontal axis illustrated the lability score in T1
while the vertical axis represented the lability score in T2. Double circles indicate two subjects with the same
lability score. Note that nonparametric correlations were calculated due to the ordinal level of the lability score.
The linear regression line is presented only for illustration purpose
Fig. 3 Scatter plot of slope indices at T1 vs. T2 (N = 27). The horizontal axis illustrated the slope index in T1
while the vertical axis illustrated the slope index in T2. The axis values are represented reversely. Note that
nonparametric correlations were calculated due to the ordinal level of the lability score. The linear regression line is
presented only for illustration purpose
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were .70 and .71, respectively (all p < .001). Thus, the EEG parameters, as classified
with VIGALL 2.0, turned out to be temporally stable, confirming some trait aspects of
brain arousal regulation.
The obtained reliabilities in the present study are well suited for applications on
group level, but should further be improved for clinical purposes, for example by more
strictly considering influencing factors as discussed below. In this context it should also
be noted that we analyzed a homogenous healthy sample and excluded subjects with
excessive sleepiness. Given this reduction of variance, high reliabilities are difficult to
obtain. One might speculate that in a clinical context, a broader range of brain arousal
regulation patterns will be found, possibly leading to higher test-retest reliabilities than
found in this homogenous healthy sample. This hypothesis is based on the findings in
previous studies that a pronounced instability or hyperstability of arousal has been
found in mania/ADHD and depression, respectively. This disease-related variance
should stay constant, whereas in healthy subject, in contrast, a floor effect, or a gener-
ally reduced variance might reduce correlations.
The parameterization of mean EEG-vigilance levels (in the current study for 20 min
and for 5-min blocks) proved to be reliable. On this basis, entering consecutive blocks
of vigilance into repeated measurement analyses enables to reliably assess group-
dependent differences in the temporal dynamics of mean EEG-vigilance levels. Such an
approach has, for instance, been pursued by Jawinski and colleagues comparing mean
EEG-vigilance levels among participants carrying zero, one or two susceptibility alleles,
respectively, of certain genetic polymorphisms linked to Bipolar Disorder (Jawinski
et al. unpublished). In our study the subjects showed significantly higher amount of
stage 0 (Z = −2.30, p = .022) and stage A (Z = −1.97, p = .049) and lower amount of B2/3
(Z = −2.15, p = .032) at T1 compared to T2, indicating overall higher arousal at T1. In
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nificantly higher (Z = −2.22, p = .026) than that at T2, and the EEG-vigilance level in
the following 5-min blocks showed a tendency in the same direction, again indicating
higher arousal at T1 (effect sizes between .19 to .49). These findings might be a conse-
quence of some “first day in lab” effects, i.e. an increased arousal due to the unfamiliar
surroundings or to anticipatory anxiety. In sleep medicine such a laboratory-induced
effect resulting in impaired sleep quality is known as “first night effect” (Agnew et al.
1966; Tamaki et al. 2005). Consequently, the validity of the parameters provided by
VIGALL 2.0 is supported, however, these findings suggest that such laboratory-induced
factors should be controlled more strictly. Longer adaptation to the lab, repeated as-
sessments or defining more strictly a baseline arousal by a demanding task before start-
ing the quiet rest period might further improve reliability.
Sleep duration can be another severe confounder in vigilance assessment (Rosenthal
et al. 1993a, Rosenthal et al. 1993b), especially in samples of young subjects who display
large variability in night sleep (Lo et al. 2014). In the current study, information about
sleep was derived by self-reports and no information about validity of this assessment
is available. In future studies objective assessments of sleep-wake-behavior or quality of
sleep prior to the EEG should be included, which could be achieved using actigraphy or
polysomnography. In addition, in the current study the subjects had not been asked
about recent stressors (e.g. examinations), which are considered as an important reason
for disturbed sleep or arousal (Sanford et al. 2014; Winzeler et al. 2014). Considering
such state effects more rigorously could further improve reliability. Another possible
confounder is the consumption of arousal modulating drugs, such as caffeine and nico-
tine (Jaehne et al. 2012; Johnson et al. 1990). This might be especially the case in clin-
ical populations, where not only smoking is highly prevalent (Lasser et al. 2000), but
also several arousal-impairing medications come into play (e.g. antidepressants; Hensch
et al. 2015). In the current healthy sample, however, smoking and caffeine was ad libi-
tum and no subject was excluded, as no excessive consume was reported and as we
tried to avoid withdrawal effect. Moreover, we did not control for effects of the men-
strual phase. If we had assessed our female subjects in the same menstrual phase at T1
and T2, we might have increased the reliability. Instead, we tried to keep our subjects
as much as possible in a “real life” condition which might have resulted in a more con-
servative estimation of the effect.
The MSLT (Carskadon and Dement 1977) was so far the only established method to
assess vigilance regulation. The MSLT, however, only assesses EEG-defined sleep onset,
disregarding information about fluctuations of vigilance before sleep onset. The MSLT
has a complex testing protocol, which requires four or five 20-min trials with 2 hours
between each trial and strongly tries to control for several of the mentioned con-
founders: Normally, the subjects arrive at the laboratory on the evening before the
MSLT. Thus, their MSLT testing is done on the second day, which probably reduces
the “first day in lab” effects. Additionally, the MSLT protocol controls factors such as
sleep duration in the preceding night and tobacco use within 30 min before testing.
Furthermore, before testing only light meals are recommended and caffeine and bright
sunlight should be avoided (for more details see Littner et al. 2005). Comparing the test-
retest reliabilities obtained in the current study with those for the MSLT is difficult due to
the dearth of studies. Almost all studies on retest reliability are on clinical groups where
Huang et al. Neuropsychiatric Electrophysiology  (2015) 1:13 Page 11 of 13reliability varies probably in accordance with varying symptomatology: Retest reliability was
non-significant in patients with hypersomnia of different etiology over a mean test-retest
interval of 4.2 years (rho = .17; Trotti et al. 2013), low in insomniacs over eight months (rho
= .44; Roehrs et al. 2011), and good in narcolepsy over an interval of 5–21 days (r = .81;
Folkerts et al. 208). Only one study in healthy subjects is available (Zwyghuizen-Doorenbos
et al. 1988), which reported a high test-retest reliability of MSLT in 14 participants (r = .97,
p < .001). A limitation of this study is certainly the small sample size in combination with
parametric correlations, which are easily inflated by one or very few subjects. Nonetheless,
the study by Zwyghuizen-Doorenbos et al. (1988) is instructive as the authors also calcu-
lated the reliabilities when the number of the MSLT test runs was reduced. The reliabil-
ity was between .65 (p < .01) and .79 (p < .008) when the test was repeated for only
two times (combined test runs 10 a.m. together with 12 p.m., and 2 p.m. with 4 p.m.,
respectively). These reliabilities of the combined scores of two MSLT runs are
numerically comparable to the test-retest reliability in the present study. When only
one single 20 min MSLT run was analyzed, reliability of the MSLT was no longer
significant for all test runs which began at afternoon (12 p.m., 2 p.m. and 4 p.m.)
(Zwyghuizen-Doorenbos et al. 1988). These findings and the current results suggest
that repeated EEG recordings might be important in cases where high reliability is
needed, such as clinical applications.
Another limitation of present study is the short test interval. A period of one week
does not allow clearly separating trait and state aspects of a variable. Arousal regulation
is strongly associated with psychopathological states, such as a depressive or manic epi-
sode, which would both last more than one week. However, in the current sample we
only analyzed healthy subjects probably limiting the influence of permanent mood
states on test retest reliability.Conclusion
EEG parameters of brain arousal regulation are promising diagnostic and prognostic
biomarkers for diseases with arousal disturbances, such as affective disorders, ADHD
and fatigue (Geissler et al. 2014; Hegerl et al. (2012); Hegerl and Hensch 2014; Kluge
et al. 2013; Olbrich et al. 2012). Here, we demonstrated in healthy subjects that the
temporal dynamics of EEG-vigilance stages across 20 min are relatively stable individual
characteristics when assessed with VIGALL 2.0. These inter-individual differences are
likely to influence results in several cognitive tasks and neurobiological assessments
such as fMRI and FDG-PET (Günther et al. 2011; Olbrich et al. 2009). By a more strict
control of state factors modulating arousal regulation (e.g. preceding sleep, nicotine,
caffeine, adaptation to the study procedure and environment) even higher reliabilities
might be achievable.Conflict of interest
Within the last three years, Prof. Hegerl was an advisory board member for Lilly, Lundbeck, Takeda Pharmaceuticals,
Servier and Otsuka Pharma and a speaker for Bristol-Myers Squibb, Medice Arzneimittel, Novartis and Roche Pharma.
The other authors do not declare any conflict of interest.Author’s contributions
JH, UH and TH conceived and designed the experiments. JH performed the experiments. JH, CS, PJ, JS and TH
analyzed the data. JH, CS, PJ, CU, UH and TH wrote and revised the paper. All authors read and approved the final
manuscript.
Huang et al. Neuropsychiatric Electrophysiology  (2015) 1:13 Page 12 of 13Acknowledgement
We acknowledge support from the German Research Foundation (DFG) and Universität Leipzig within the program of
Open Access Publishing.
Author details
1Department of Psychiatry and Psychotherapy, University of Leipzig, Semmelweisstr. 10, Leipzig 04103, Germany.
2LIFE – Leipzig Research Center for Civilization Diseases, Universität Leipzig, Leipzig, Germany. 3Depression
Research Centre of the German Depression Foundation, Leipzig, Germany.
Received: 31 March 2015 Accepted: 2 June 2015
References
Agnew HW, Webb WB, Williams RL (1966) The first night effect: an EEG study of sleep. Psychophysiology 2(3):263–6
Akerstedt T, Gillberg M (1990) Subjective and objective sleepiness in the active individual. Int J Neurosci 52(1–2):29–37.
doi:10.3109/00207459008994241
Benca RM, Obermeyer WH, Larson CL, Yun B, Dolski I, Kleist KD, Weber SM, Davidson RJ (1999) EEG alpha power and alpha
power asymmetry in sleep and wakefulness. Psychophysiology 36(4):430–6. doi:10.1111/1469-8986.3640430
Bente D (1964) Vigilanz, dissoziative Vigilanzverschiebung und Insuffizienz des Vigilanztonus. In: Kranz H, Heinrich
K (eds) Begleitwirkungen und Misserfolge der psychiatrischen Pharmakotherapie. Germany, Stuttgart
Cantero JL, Atienza M, Salas RM (2002) Human alpha oscillations in wakefulness, drowsiness period, and REM sleep:
different electroencephalographic phenomena within the alpha band. Neurophysiol Clin/Clin Neurophysiol
32(1):54–71. doi:10.1016/S0987-7053(01)00289-1
Carskadon MA, Dement WC (1977) Sleepiness and sleep state on a 90-min schedule. Psychophysiology 14(2):127–33.
doi:10.1111/j.1469-8986.1977.tb03362.x
Cohen J (1988) Statistical power analysis for the behavioral science, 2nd edn. Lawrence Erlbaum Associates, Hillsdale.
ISBN 978-0805802832
Corsi-Cabrera M, Guevara MA, Del Río-Portilla Y, Arce C, Villanueva-Hernández Y (2000) EEG bands during
wakefulness, slow-wave and paradoxical sleep as a result of principal component analysis in man. Sleep 23(6):738–44
Cuthbert BN, Insel TR (2013) Toward the future of psychiatric diagnose: the seven pillars of RDoC. BMC Med 11:126.
doi:10.1186/1741-7015-11-126
De Gennaro L, Ferrara M (2003) Sleep spindles: an overview. Sleep Med Rev 7(5):423–40. doi:10.1053/smrv.2002.0252
De Gennaro L, Ferrara M, Curcio G, Cristiani R (2001) Antero-posterior EEG changes during the wakefulness–sleep transition. Clin
Neurophysiol 112(10):1901–11. doi:10.1016/S1388-2457(01)00649-6
De Gennaro L, Vecchio F, Ferrara M, Curcio G, Rossini PM, Babiloni C (2004) Changes in fronto-posterior functional
coupling at sleep onset in humans. J Sleep Res 13(3):209–17. doi:10.1111/j.1365-2869.2004.00406.x
De Gennaro L, Vecchio F, Ferrara M, Curcio G, Rossini PM, Babiloni C (2005) Antero-posterior functional coupling at
sleep onset: changes as a function of increased sleep pressure. Brain Res Bull 65(2):133–40. doi:10.1016/
j.brainresbull.2004.12.004
Folkerts M, Rosenthal L, Roehrs T, Krstevska S, Murlidhar A, Zorick F, Wittig R, Roth T (2008) The reliability of the
diagnostic features in patients with narcolepsy. Biol Psychiatry 40(3):214. doi:10.1016/0006-3223(95)00383-5
Geissler J, Romanos M, Hegerl U, Hensch T (2014) Hyperactivity and sensation seeking as autoregulatory attempts to
stabilize brain arousal in ADHD and mania? ADHD 6(3):159–73. doi:10.1007/s12402-014-0144-z
Günther T, Schönknecht P, Becker G, Olbrich S, Sander C, Hesse S, Meyer PM, Luthardt J, Hegerl U, Sabri O (2011)
Impact of EEG-vigilance on brain glucose uptake measured with [(18) F] FDG and PET in patients with depressive
episode or mild cognitive impairment. NeuroImage 56(1):93–101. doi:10.1016/j.neuroimage.2011.01.059
Hegerl U, Hensch T (2014) The vigilance regulation model of affective disorders and ADHD. Neurosci Biobehav Rev
44:45–57. doi:10.1016/j.neubiorev.2012.10.008
Hegerl U, Wilk K, Olbrich S, Schönknecht P, Sander C (2012) Hyperstable regulation of vigilance in patients with major
depressive disorder. World J Biol Psychiatry 13(6):436–46. doi:10.3109/15622975.2011.579164
Hegerl U, Hensch T, Böttger D, Sander C (2014) VIGALL 2.0: Analyzing different functional brain states and their
regulation during resting states, Brain Products Press Release., http://pressrelease.brainproducts.com/vigall/
Hensch T, Blume A, Böttger D, Sander C, Niedermeier N, Hegerl U (2015) Yawning in depression: worth looking into.
Pharmacopsychiatry 48(3):118–20
Iber C, Ancoli-Israel S, Chesson A, Quan SF (2008) Das AASM-Manual zum Scoring von Schlaf und assoziierten Ereignissen:
Regeln, Technologie und technische Spezifikationen, 1st edn. Steinkopff, Germany
Jaehne A, Unbehaun T, Feige B, Lutz UC, Batra A, Riemann D (2012) How smoking affects sleep: A polysomnographical
analysis. Sleep Med 13(10):1286–92. doi:10.1016/j.sleep.2012.06.026
Johns MW (1992) Reliability and factor analysis of the Epworth sleepiness scale. Sleep 15(4):376–81
Johnson LC, Spinweber CL, Gomez SA (1990) Benzodiazepines and caffeine: effect on daytime sleepiness, performance
and mood. Psychopharmacology (Berl) 101:160–7
Kaida K, Takahashi M, Åkerstedt T, Nakata A, Otsuka Y, Haratani T, Fukasawa K (2006) Validation of the Karolinska
sleepiness scale against performance and EEG variables. Clin Neuropathol 117(7):1574–81. doi:10.1016/
j.clinph.2006.03.011
Kluge M, Hegerl U, Sander C, Dietzel J, Mergl R, Bitter I, Demyttenaere K, Gusmão R, Gonzalez-Pinto A, Perez-Sola V, Vieta
E, Juckel G, Zimmermann US, Bauer M, Sienaert P, Quintão S, Edel MA, Bolyos C, Ayuso-Mateos JL, López-García P (2013)
Methylphenidate in mania project (MEMAP): study protocol of an international randomised double-blind
placebo-controlled study on the initial treatment of acute mania with methylphenidate. BMC Psychiatry 13:71.
doi:10.1186/1471-244×-13-71
Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH (2000) Smoking and mental illness:
A population-based prevalence study. JAMA 284(20):2606–10. doi:10.1001/jama.284.20.2606
Huang et al. Neuropsychiatric Electrophysiology  (2015) 1:13 Page 13 of 13Littner MR, Kushida C, Wise M, Davila DG, Morgenthaler T, Lee-Chiong T, Hirshkowitz M, Daniel LL, Bailey D, Berry
RB, Kapen S, Kramer M, Standards of Practice Committee of the American Academy of Sleep Medicine (2005)
Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test.
Sleep 28(1):113–21
Lo JC, Leong RL, Loh KK, Dijk DJ, Chee MW (2014) Young adults’ sleep duration on work days: Differences between
East and West. Front Neurol 5:81. doi:10.3389/fneur.2014.00081
Loomis AL, Harvey EN, Hobart GA (1937) Cerebral states during sleep, as studied by human brain potentials. J Exp
Psychol 21(2):127–44
Marzano C, Fratello F, Moroni F, Pellicciari MC, Curcio G, Ferrara M, Ferlazzo F, De Gennaro L (2007) Slow eye
movements and subjective estimates of sleepiness predict EEG power changes during sleep deprivation. Sleep
30(5):610–6
Olbrich S, Mulert C, Karch S, Trenner M, Leicht G, Pogarell O, Hegerl U (2009) EEG-vigilance and BOLD effect during
simultaneous EEG/fMRI measurement. NeuroImage 45(2):319–32. doi:10.1016/j.neuroimage.2008.11.014
Olbrich S, Jödicke J, Sander C, Himmerich H, Hegerl U (2011a) ICA-based muscle artefact correction of EEG data: What
is muscle and what is brain? NeuroImage 54(1):1–3. doi:10.1016/j.neuroimage.2010.04.256
Olbrich S, Sander C, Matschinger H, Mergl R, Trenner M, Schönknecht P, Hegerl U (2011b) Brain and Body.
J Psychophysiol 25(4):190–200. doi:10.1027/0269-8803/a000061
Olbrich S, Sander C, Minkwitz J, Chittka T, Mergl R, Hegerl U, Himmerich H (2012) EEG vigilance regulation patterns and
their discriminative power to separate patients with major depression from healthy controls. Neuropsychobiology
65(4):188–94. doi:10.1159/000337000
Olbrich S, Olbrich H, Jahn I, Sander C, Adamaszek M, Hegerl U, Reque F, Stengler K (2013) EEG-vigilance regulation
during the resting state in obsessive–compulsive disorder. Clin Neuropathol 124(3):497–502. doi:10.1016/
j.clinph.2012.08.018
Pascual-Marqui RD, Esslen M, Kochi K, Lehmann D (2002) Functional imaging with low-resolution brain electromagnetic
tomography (LORETA): a review. Methods Find Exp Clin Pharmacol 24(Suppl C):91–5
Pascual-Marqui RD, Michel CM, Lehmann D (1994) Low resolution electromagnetic tomography: a new method for
localizing electrical activity in the brain. Int J Psychophysiol 18(1):49–65. doi:10.1016/0167-8760(84)90014-X
Pfaff D, Ribeiro A, Matthews J, Kow LM (2008) Concept and mechanisms of generalized central nervous system arousal.
Ann N Y Acad Sci 1129:11–25. doi:10.1196/annals.1417.019
Rechtschaffen A, Kales A, University of California, LABIS (1969) A Manual of Standardized Terminology, Techniques and
Scoring System for Sleep Stages of Human Subjects: A. Rechtschaffen and A. Kales (Editors). 26(6): 644–702. doi:
10.1016/0013-4694(69)90021-2.
Roehrs TA, Randall S, Harris E, Maan R, Roth T (2011) MSLT in primary insomnia: stability and relation to nocturnal sleep.
Sleep 34(12):1647–52. doi:10.5665/sleep.1426
Rosenthal L, Roehrs TA, Rosen A, Roth T (1993a) Level of sleepiness and total sleep time following various time in bed
conditions. Sleep 16(3):226–32
Rosenthal L, Roehrs TA, Roth T (1993b) The sleep-wake activity inventory: A self-report measure of daytime sleepiness.
Biol Psychiatry 34(11):810–20. doi:10.1016/0006-3223(93)90070-T
Roth B (1961) The clinical and theoretical importance of EEG rhythms corresponding to states of lowered vigilance.
Electromyogr Clin Neurophysiol 13(3):395–9. doi:10.1016/0013-4694(61)90008-6
Sander C, Arns M, Olbrich S, Hegerl U (2010) EEG-vigilance and response to stimulants in paediatric patients with
attention deficit/hyperactivity disorder. Clin Neurophysiol 121(9):1511–8. doi:10.1016/j.clinph.2010.03.021
Sander C, Hensch T, Wittekind DA, Böttger D, Hegerl U (in press) Assessment of wakefulness and vigilance regulation.
Neuropsychobiology.
Sanford LD, Suchecki D, Meerlo P (2014) Stress, Arousal, and Sleep, Current Topics in Behavioral Neurosciences..
doi:10.1007/7854_2014_314
Strijkstra AM, Beersma DG, Drayer B, Halbesma N, Daan S (2003) Subjective sleepiness correlates negatively with global
alpha (8–12 Hz) and positively with central frontal theta (4–8 Hz) frequencies in the human resting awake
electroencephalogram. Neurosci Lett 340(1):17–20. doi:10.1016/S0304-3940(03)00033-8
Tamaki M, Nittono H, Hayashi M, Hori T (2005) Examination of the first-night effect during the sleep-onset period. Sleep
28(2):195–202
Trotti LM, Staab BA, Rye DB (2013) Test-retest reliability of the multiple sleep latency test in narcolepsy without cataplexy and
idiopathic hypersomnia. J Clin Sleep Med 9(8):789–95. doi:10.5664/jcsm.2922
Tsuno N, Shigeta M, Hyoki K, Kinoshita T, Ushijima S, Faber PL, Lehmann D (2002) Spatial organization of EEG activity
from alertness to sleep stage 2 in old and younger subjects. J Sleep Res 11(1):43–51. doi:10.1046/j.1365-
2869.2002.00288.x
Winzeler K, Voellmin A, Schäfer V, Meyer AH, Cajochen C, Wilhelm FH, Bader K (2014) Daily stress, presleep arousal, and
sleep in healthy young women: a daily life computerized sleep diary and actigraphy study. Sleep Med 15(3):359–66.
doi:10.1016/j.sleep.2013.09.027
Zwyghuizen-Doorenbos A, Roehrs T, Schaefer M, Roth T (1988) Test-retest reliability of the MSLT. Sleep 11(6):562–5
